Ex vivo assessment of targeted therapies in a rare metastatic epithelial–myoepithelial carcinoma
Epithelial–myoepithelial carcinoma (EMC) is a rare subtype of salivary gland neoplasms. Since the initial description of the cancer, just over 300 cases have been reported. EMCs occupy a biphasic cellular differentiation-state defined by the constitution of two cell types representing epithelial and...
Main Authors: | Rami Mäkelä, Antti Arjonen, Aldwin Suryo Rahmanto, Ville Härmä, Janne Lehtiö, Teijo Kuopio, Thomas Helleday, Olle Sangfelt, Juha Kononen, Juha K. Rantala |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558620301299 |
Similar Items
-
Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma
by: Rami Mäkelä, et al.
Published: (2020-06-01) -
Ex Vivo Drug Screening Informed Targeted Therapy for Metastatic Parotid Squamous Cell Carcinoma
by: Noora Nykänen, et al.
Published: (2021-09-01) -
Clear cell myoepithelial carcinoma ex pleomorphic adenoma
by: Nikhil R Rabade, et al.
Published: (2014-01-01) -
Myoepithelial Carcinoma of the Breast
by: Santhosh R, et al.
Published: (2013-06-01) -
Primary myoepithelial carcinoma of palate
by: Yang Ya, et al.
Published: (2011-09-01)